Organoidsciences Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-11,246	-38,687	-24,111
Depreciation & Amortization	1,304	1,144	804.46
Loss (Gain) From Sale of Investments	-163.05	-43.05	-
Stock-Based Compensation	969.5	979.19	542.39
Other Operating Activities	79.15	29,853	13,990
Change in Accounts Receivable	149.39	-393.5	0.78
Change in Inventory	26.82	-26.23	-
Change in Accounts Payable	0.74	14.88	-
Change in Income Taxes	-	0.74	-
Change in Other Net Operating Assets	-260.43	-90.48	256.22
Operating Cash Flow	-9,141	-7,248	-8,518
Capital Expenditures	-667.07	-947.83	-1,787
Sale of Property, Plant & Equipment	-	6.16	-
Sale (Purchase) of Intangibles	-120.21	-70.5	-16.88
Investment in Securities	5,761	5,632	-25,434
Other Investing Activities	-48.27	-19.93	-1,094
Investing Cash Flow	4,925	4,600	-28,332
Short-Term Debt Issued	3,000	-	300
Long-Term Debt Issued	700	-	-
Total Debt Issued	3,700	-	300
Short-Term Debt Repaid	-300	-	-
Long-Term Debt Repaid	-217.49	-218	-231.04
Total Debt Repaid	-517.49	-218	-231.04
Net Debt Issued (Repaid)	3,183	-218	68.96
Issuance of Common Stock	200	250	-
Other Financing Activities	280.79	148.42	218.27
Financing Cash Flow	3,663	180.43	11,286
Foreign Exchange Rate Adjustments	44.82	-74.93	-
Net Cash Flow	-507.22	-2,543	-25,563
Free Cash Flow	-9,808	-8,196	-10,304
Free Cash Flow Margin	-502.11%	-515.13%	-2351.33%
Free Cash Flow Per Share	-2346.59	-2859.93	-3595.68
Cash Interest Paid	301.32	341.67	123.02
Cash Income Tax Paid	-34.04	114.09	-
Levered Free Cash Flow	-68,924	15,049	-
Unlevered Free Cash Flow	-66,930	18,794	-
Change in Working Capital	-83.47	-494.59	257

Source: S&P Global Market Intelligence. Standard template. Financial Sources.